BG
BHVN icon

Bellevue Group’s Biohaven BHVN Stock Holding History

Bellevue Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,802,853
Closed -$42.1M – 180
2025
Q3 		$42.1M Hold
2,802,853
– – 0.87% 30
2025
Q2 		$39.5M Buy
2,802,853
+762,000
+37% +$13.6M 0.87% 28
2025
Q1 		$49.1M Hold
2,040,853
– – 1.1% 23
2024
Q4 		$76.2M Hold
2,040,853
– – 1.47% 22
2024
Q3 		$102M Hold
2,040,853
– – 1.65% 17
2024
Q2 		$70.8M Buy
2,040,853
+890,853
+77% +$35.2M 1.15% 22
2024
Q1 		$62.9M Buy
1,150,000
+75,000
+7% +$3.71M 0.96% 28
2023
Q4 		$46M Buy
+1,075,000
New +$33.4M 0.7% 45

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group's BHVN Position: Q4 2025 in Review

Bellevue Group sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 2,802,853 shares — an estimated $42.1M sold.

Bellevue Group first reported a position in BHVN in Q4 2023 and held it in 8 quarters. The position peaked at $102M in Q3 2024. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Bellevue Group reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Bellevue Group sold 2,802,853 Biohaven shares in Q4 2025, an estimated $42.1M.
  • Bellevue Group first reported a position in Biohaven in Q4 2023 and held it in 8 quarters.
  • Bellevue Group's Biohaven position peaked at $102M in Q3 2024.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Bellevue Group's 13F filing for Q4 2025, filed 17 Feb 2026.